Article: Prion protein monoclonal antibody (PRN100) therapy for Creutzfeldt–Jakob disease: evaluation of a first-in-human treatment programme
TLN_April2022_p342_354 (pdf)
The Lancet Neurology April2022 p342_354 (online)
from The Lancet Neurology
Article: Prion protein monoclonal antibody (PRN100) therapy for Creutzfeldt–Jakob disease: evaluation of a first-in-human treatment programme
TLN_April2022_p342_354 (pdf)
The Lancet Neurology April2022 p342_354 (online)
from The Lancet Neurology
2 days ago
1 week ago
2 weeks ago
3 weeks ago
Why the ION717 trial is paused
Probably because they filled the lowest dose group and need to analyze the safety and pharmacology data before escalating to a higher dose.4 weeks ago
© 2024 CJD Support Group Network Australia.
The CJDSGN acknowledges the funding provided by the Department of Health
that assists towards the cost of this website.
Disclaimer Privacy Policy